(b)(4).Manufacturer's investigation conclusion: a direct relationship between the device and the reported renal dysfunction, multiorgan failure, sepsis, patient conditions (vasoplegia and hemodynamic compromise), and patient outcome could not be conclusively determined through this evaluation.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) lists renal dysfunction, multiple organ failures/dysfunctions, and sepsis as adverse events that may be associated with the use of heartmate 3 lvas.Care instructions regarding preventing infection are provided in various sections of the ifu.The heartmate 3 lvas patient handbook provides care instructions regarding preventing infection.No further information was provided.The manufacturer is closing the file on this event.
|